- Treatment for soft tissue sarcoma in childhood and adolescence. Austrian results within the CWS 96 studyDitha Modritz
CCRI Children s Cancer Research Institute St Anna Kinderspital, Wien Osterreichische Studienzentrale, Vienna, Austria
Wien Klin Wochenschr 117:196-209. 2005..The aim of the CWS 96 Study was to achieve an optimal treatment in children and adolescents with soft tissue sarcoma (STS) implementing a further refinement of risk-adapted allocation to chemotherapy, surgery and radiotherapy...
- Dose finding study for the use of subcutaneous recombinant interleukin-2 to augment natural killer cell numbers in an outpatient setting for stage 4 neuroblastoma after megatherapy and autologous stem-cell reinfusionRuth Ladenstein
St Anna Children s Hospital, Vienna, Austria
J Clin Oncol 29:441-8. 2011....
- Randomized Trial of prophylactic granulocyte colony-stimulating factor during rapid COJEC induction in pediatric patients with high-risk neuroblastoma: the European HR-NBL1/SIOPEN studyRuth Ladenstein
St Anna Children s Hospital, Kinderspitalgasse 6, Vienna, Austria
J Clin Oncol 28:3516-24. 2010....
- Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trialRuth Ladenstein
St Anna Children s Hospital, SIRP CCRI Studies and Statistics on Integrated Research and Projects, Children s Cancer Research Institute, Vienna, Austria
J Clin Oncol 28:3284-91. 2010..To improve the poor prognosis of patients with primary disseminated multifocal Ewing sarcomas (PDMES) with a dose-intense treatment concept...
- Disseminated tumor cells in the bone marrow - chances and consequences of microscopical detection methodsPeter F Ambros
Children s Cancer Research Institute, St Anna Children s Hospital, Kinderspitalgasse 6, A 1090 Vienna, Austria
Cancer Lett 197:29-34. 2003....
- Neuroblastoma mRNAs predict outcome in children with stage 4 neuroblastoma: a European HR-NBL1/SIOPEN studyVirginie F Viprey
Virginie F Viprey and Susan A Burchill, Leeds Institute of Cancer and Pathology Walter M Gregory, Clinical Trials Research Unit, University of Leeds, Leeds Penelope Brock, Great Ormond Street Hospital, London Andrew D Pearson, Institute of Cancer Research Royal Marsden National Health Service Foundation Trust, Sutton, United Kingdom Maria V Corrias and Sandro Dallorso, Gaslini Institute, Genoa Roberto Luksch, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milano, Italy Andrei Tchirkov, Centre Hospitalier Universitaire Clermont Ferrand and Clermont Université, Universite d Auvergne, Clermont Ferrand Dominique Valteau Couanet, Institut Gustave Roussy, Villejuif, France Katrien Swerts and Genevieve Laureys, University Hospital Ghent, Ghent, Belgium Ales Vicha, Charles University and University Hospital Motol, Prague, Czech Republic Vassilios Papadakis, Agia Sofia Children s Hospital, Athens, Greece and Ruth Ladenstein, Children s Cancer Research Institute St Anna Children s Hospital, Vienna, Austria
J Clin Oncol 32:1074-83. 2014....
- Bone marrows from neuroblastoma patients: an excellent source for tumor genome analysesM Reza Abbasi
Tumor Biology, Children s Cancer Research Institute, St Anna Kinderkrebsforschung, Vienna, Austria Electronic address
Mol Oncol 9:545-54. 2015....
- A multilocus technique for risk evaluation of patients with neuroblastomaInge M Ambros
CCRI, Children s Cancer Research Institute, St Anna Kinderkrebsforschung, Vienna, Austria
Clin Cancer Res 17:792-804. 2011..We present the establishment and validation of the PCR-based multiplex ligation-dependent probe amplification (MLPA) technique for neuroblastoma...
- Metronomic topotecan impedes tumor growth of MYCN-amplified neuroblastoma cells in vitro and in vivo by therapy induced senescenceSabine Taschner-Mandl
CCRI, Chlidren s Cancer Research Institute, Vienna, Austria
Oncotarget 7:3571-86. 2016....
- Performance of a new separator system for routine autologous hematopoietic progenitor cell collection in small childrenVolker Witt
St Anna Kinderspital, Vienna, Austria
J Clin Apher 22:306-13. 2007..With the AMICUS we saw statistically less citrate reactions compared to the CS 3000. We conclude that the AMICUS system is safe and efficient to harvest PBSC on a routine basis in pediatric patients, even in children < or =10 kg bw...
- Detection of disseminated tumor cells in neuroblastoma: 3 log improvement in sensitivity by automatic immunofluorescence plus FISH (AIPF) analysis compared with classical bone marrow cytologyGabor Mehes
Children s Cancer Research Institute, St Anna Children s Hospital, Vienna, Austria
Am J Pathol 163:393-9. 2003..Thus, the immunofluorescence technique offers an excellent tool for reliable detection and quantification of disseminated tumor cells at diagnosis and during the course of the disease...